PTCT FY 2018 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$5B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$265M+36.2% YoY

Gross Profit

$252M95.2% margin

Operating Income

-$116M-43.7% margin

Net Income

-$128M-48.4% margin

EPS (Diluted)

$-2.75

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$43M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$768M

Stockholders' Equity

$351M

Cash & Equivalents

$228M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$265M	$194M	+36.2%
Gross Profit	$252M	$190M	+32.8%
Operating Income	-$116M	-$64M	-79.9%
Net Income	-$128M	-$79M	-62.1%